Curaleaf has released its Ground Flower Pods on a limited basis in New York, marking the first time a flower product has been made available under the state’s medical cannabis program. The company said that while the pods – designed to be used with a vaporizer – are currently only available on a limited basis, they will be available throughout the state in the coming weeks.
Joseph Lusardi, CEO of Curaleaf, called the product “a win” for the state’s medical cannabis patients.
“Flower is cannabis in its raw form and therefore the most affordable form of cannabis. We can increase patient access by providing more affordable products and offering more options for patients in the medical program.” – Lusardi, in a statement
The Health Department approved the addition of some flower products to the regime last year; however, sales of purely raw forms of cannabis are still not permitted. In the action, the agency also added lozenges, chewable tablets, and topicals to the list of products approved for sale in dispensaries.
The Ground Flower Pods must be used with the company’s tabletop vaporizer. Each pod contains 350 milligrams of active cannabinoids in a 20:1 THC to CBD ratio in both Indica and Sativa strains.
Curaleaf operates in 12 states with 49 dispensaries, 14 cultivation sites, and 13 processing centers. As of Sept. 17, there were 107,111 registered patients and 2,504 registered practitioners in the state.
Get daily cannabis business news updates. Subscribe